Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > More Bad News for Biogen's Aducanumab "Worst Decision"
View:
Post by KingAbeNYC on Sep 27, 2021 11:35am

More Bad News for Biogen's Aducanumab "Worst Decision"

The road to Aduhelm: What one ex-FDA adviser called 'probably the worst drug approval decision in recent US history' for an Alzheimer's treatment


https://www.cnn.com/2021/09/26/politics/alzheimers-drug-aduhelm-fda-approval/index.html
Comment by DavidKingCanada on Sep 27, 2021 11:37am
Note; Biogen's Stock is back to the levels it was PRE-Approval - 280.00 USD
Comment by retiredcop on Sep 27, 2021 12:32pm
Excellent news for us..everyone sees a problem.. And are anxously looking for an alternative....
Comment by JackRedwood on Sep 27, 2021 1:22pm
I sure hope PMN receives more coverage! 
Comment by retiredcop on Sep 27, 2021 1:39pm
No doubt they will receive a lot of coverage but not until the boots hit the dirt, the shovels are in the ground , the catering truck has arrived because right now its just a plan and there are numerous ones out there .. so basically its still ALL TALK and nothing else . We need the real first indicator which is the notice to the regulators that PMN is actually proceeding with the clinicals ...more  
Comment by Speyeder999 on Sep 27, 2021 2:18pm
RC, what do you suppose the chances of hearing news on cell line development before year's end are?
Comment by bball67 on Sep 27, 2021 2:48pm
I recall it was in corporate presentation of several months ago, with a 4th quarter 2021 target date. 
Comment by JackRedwood on Sep 27, 2021 2:56pm
Great info, thanks! 
Comment by retiredcop on Sep 27, 2021 3:21pm
That sounds about right 6 to 7 months from the time the manufacturer got word to start 
Comment by Speyeder999 on Sep 27, 2021 3:58pm
Thanks for all the replies. 4 quarter begins this week! Encouraging!
Comment by retiredcop on Sep 27, 2021 5:11pm
I strongly believe that we will see Advanced Life Support news before anything ...
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities